Back to Results
First PageMeta Content
Anatomy / Diabetes / Lipodystrophy / Obesity / Tissues / Leptin / Insulin resistance / Adipose tissue / Insulin / Biology / Endocrine system / Peptide hormones


Document Date: 2014-11-03 11:26:24

Open Document

File Size: 31,46 KB

Share Result on Facebook

City

Osaka / /

Company

Shionogi & Co. Ltd. / Amylin Pharmaceuticals Inc. / Corporate Communications Department Shionogi & Co. Ltd. / /

Country

Japan / United States / /

Facility

Kyoto University Hospital / Translational Research Center / University Graduate School / /

/

IndustryTerm

foreign healthcare reforms / with respect to product / /

MedicalCondition

leptin deficiency / Lipodystrophy Lipodystrophy / insulin resistance / Lipodystrophy / disease / severe insulin resistance / diabetes / hyperlipidemia / severe diabetes / rare and life-threatening disorder / Intractable Diseases / hypertriglyceridemia and fatty liver disease / /

Organization

Kyoto University Graduate School / Department of Medicine and Clinical Science / Kyoto University Hospital / Translational Research Center / Ministry of Health / /

Person

Isao Teshirogi / /

/

Position

President & CEO / /

PublishedMedium

Clinical Science / /

Technology

Drug Discovery / /

SocialTag